Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

223.43 +4.41 (+2.01%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,067,103
Open 218.75
Bid (Size) 223.20 (300)
Ask (Size) 225.00 (100)
Prev. Close 219.02
Today's Range 218.50 - 225.82
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 3.10%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
The life sciences sector has entered 2026 in the midst of a historic transformation, as deal volume and value surged by a staggering 82% over the past year. This "Great Rebound," fueled by a... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal ↗
Via MarketBeat

Performance

YTD
-2.6%
-2.6%
1 Month
-4.3%
-4.3%
3 Month
+1.9%
+1.9%
6 Month
+12.8%
+12.8%
1 Year
+15.8%
+15.8%

More News

Read More
News headline image
ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds
Via StockStory
AbbVie Inc. (NYSE:ABBV) Raises 2026 Outlook Despite Q4 Revenue Miss ↗
Via Chartmill
News headline image
AbbVie (ABBV) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
AbbVie’s (NYSE:ABBV) Q4 CY2025: Beats On Revenue
Via StockStory
News headline image
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie (ABBV) Q4 Earnings: What To Expect
Via StockStory
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
Where Will AbbVie Be in 5 Years? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
2 No-Brainer Dividend Stocks to Buy Hand Over Fist ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Better Long-Term Buy: This Emerging Player or the Industry Leader? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Why AbbVie Stock Trounced the Market in 2025 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Reinforces Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
Via MarketMinute
News headline image
Why Revolution Medicines Stock Plummeted by Almost 17% Today ↗
Via The Motley Fool
News headline image
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
Via Finterra
Topics Economy Initial Public Offering
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
Via Finterra
Topics Intellectual Property
News headline image
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income ↗
Via The Motley Fool
Topics Stocks
News headline image
My Top 4 Stocks to Buy in Early 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation
Via MarketMinute
Topics Bankruptcy Lawsuit World Trade

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 223.43
When was AbbVie last traded?
The last trade of AbbVie was at 02/06/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.